Verona Pharma plc ADR (VRNA)
NGM · ADR · CUSIP 925050106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for VRNA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
925050106
Market Cap
Micro Cap · $92 Million
IPO
4/26/2017 · $13.50/share
ADR Ratio
1:8
Business: Verona Pharma plc is a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs.

Company Contact

CEO
David Zaccardelli
CFO
Mark W. Hahn
Investor Relations
Argot Partners · 212-600-1902 · verona@argotpartners.com
General Email
ir@veronapharma.com
SEC EDGAR Filings
View filings »